The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer (STARPAC2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04241276
Recruitment Status : Active, not recruiting
First Posted : January 27, 2020
Last Update Posted : June 6, 2024
Medical Research Council
Information provided by (Responsible Party):
Queen Mary University of London

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 30, 2024
Estimated Study Completion Date : May 29, 2025